Optecure® and Optecure® +ccc DBM Bone Graft
Presenting the cure for your bone graft performance concerns.
Optecure ® and Optecure ® +ccc DBM Bone Graft
Presenting the cure for your bone graft performance concerns.
Optecure ® and Optecure ® +ccc
Optecure® is an engineered bone graft for reconstruction of the spine, pelvis and extremities. Its room temperature convenience facilitates rapid mixing with buffer solution, blood or autogenous bone graft (ABG).
With cortical cancellous bone chips, Optecure+ccc also provides a 3-D matrix for osteoconductivity. The convenience, constituents and robust handling properties make Optecure the optimal cure for your concerns about bone graft performance.
Optecure ®
Inductive
Demineralized Bone Matrix (DBM)
- Optimal 81 percent concentration of DBM by dry weight for Optecure1,2
- 100 percent lot tested for sterility
- 100 percent lot tested in-vivo for osteoinductivity
- 100 percent lot tested for endotoxins
Carrier
-
100 percent lot tested for sterility
-
Resistant to diluent migration1
-
Intra-operative flexibility to craft the desired handling characteristics1
-
100 percent lot tested for endotoxins
-
Optecure ® +ccc
Inductive/Conductive
Optecure +ccc contains all of the characteristics of Optecure plus:
Cortical Cancellous Chips (ccc)
-
Gamma irradiated
-
Sized approximately 1-3mm
-
100 percent lot tested for endotoxins
-
100 percent lot tested for sterility
-
Resources
References
References
- Data on file at Exactech.
- Keller T, et al. Carriers may change osteoinductivity of human demineralized bone in the athymic mouse. The 32nd annual Meeting and Exhibition of the American Academy of Dental Research. 2003 Mar.